BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 26032175)

  • 1. New insight in the treatment of refractory melasma: Laser Q-switched Nd: YAG non-ablative fractionated followed by intense pulsed light.
    Cunha PR; Pinto CA; Mattos CB; Cabrini DP; Tolosa JL
    Dermatol Ther; 2015; 28(5):296-9. PubMed ID: 26032175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of melasma with low fluence, large spot size, 1064-nm Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser for the treatment of melasma in Fitzpatrick skin types II-IV.
    Brown AS; Hussain M; Goldberg DJ
    J Cosmet Laser Ther; 2011 Dec; 13(6):280-2. PubMed ID: 21992660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-fluence Q-switched Nd: YAG 1064-nm laser and intense pulsed light for the treatment of melasma.
    Vachiramon V; Sirithanabadeekul P; Sahawatwong S
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1339-46. PubMed ID: 25413592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser.
    Alsaad SM; Ross EV; Mishra V; Miller L
    Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of melasma with mixed parameters of 1,064-nm Q-switched Nd:YAG laser toning and an enhanced effect of ultrasonic application of vitamin C: a split-face study.
    Lee MC; Chang CS; Huang YL; Chang SL; Chang CH; Lin YF; Hu S
    Lasers Med Sci; 2015 Jan; 30(1):159-63. PubMed ID: 25073866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
    Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP
    Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results in low-fluence 1064-nm Q-Switched Nd:YAG laser for melasma: Is it effective?
    Gokalp H; Akkaya AD; Oram Y
    J Cosmet Dermatol; 2016 Dec; 15(4):420-426. PubMed ID: 27349828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-power fractional CO₂ laser versus low-fluence Q-switch 1,064 nm Nd:YAG laser for treatment of melasma: a randomized, controlled, split-face study.
    Jalaly NY; Valizadeh N; Barikbin B; Yousefi M
    Am J Clin Dermatol; 2014 Aug; 15(4):357-63. PubMed ID: 24858737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of dual-pulsed 1064 nm Q-switched Nd:YAG laser and single-pulsed 1064 nm Q-switched Nd:YAG laser by using zebrafish model and prospective split-face analysis of facial melasma.
    Jang HW; Chun SH; Park HC; Ryu HJ; Kim IH
    J Cosmet Laser Ther; 2017 Apr; 19(2):114-123. PubMed ID: 27911108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retreatment using a dual mode of low-fluence Q-switched and long-pulse Nd:YAG laser in patients with melasma aggravation after previous therapy.
    Choi CP; Yim SM; Seo SH; Ahn HH; Kye YC; Choi JE
    J Cosmet Laser Ther; 2015 Jun; 17(3):129-34. PubMed ID: 25415369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study of a novel dual--pulsed 1064 nm Q-switched Nd: YAG laser to treat Riehl's melanosis.
    Chung BY; Kim JE; Ko JY; Chang SE
    J Cosmet Laser Ther; 2014 Dec; 16(6):290-2. PubMed ID: 25046351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of melasma by low-fluence 1064 nm Q-switched Nd:YAG laser.
    Sim JH; Park YL; Lee JS; Lee SY; Choi WB; Kim HJ; Lee JH
    J Dermatolog Treat; 2014 Jun; 25(3):212-7. PubMed ID: 23030603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel technique to treat melasma in Chinese: The combination of 2940-nm fractional Er:YAG and 1064-nm Q-switched Nd:YAG laser.
    Tian WC
    J Cosmet Laser Ther; 2016; 18(2):72-4. PubMed ID: 26836057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study on efficacy of high and low fluence Q-switched Nd:YAG laser and glycolic acid peel in melasma.
    Kar HK; Gupta L; Chauhan A
    Indian J Dermatol Venereol Leprol; 2012; 78(2):165-71. PubMed ID: 22421647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination treatment of low-fluence 1,064-nm Q-switched Nd: YAG laser with novel intense pulse light in Korean melasma patients: a prospective, randomized, controlled trial.
    Yun WJ; Moon HR; Lee MW; Choi JH; Chang SE
    Dermatol Surg; 2014 Aug; 40(8):842-50. PubMed ID: 25022705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Q-switched Nd: YAG laser alone or with modified Jessner chemical peeling for treatment of mixed melasma in dark skin types: A comparative clinical, histopathological, and immunohistochemical study.
    Saleh F; Moftah NH; Abdel-Azim E; Gharieb MG
    J Cosmet Dermatol; 2018 Jun; 17(3):319-327. PubMed ID: 29057567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 1064 nm Q-switched Nd:YAG laser and Jessner peeling in melasma treatment.
    Ertam Sagduyu I; Marakli O; Oraloglu G; Bulut Okut E; Unal I
    Dermatol Ther; 2022 Dec; 35(12):e15970. PubMed ID: 36346028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of melasma with a low-fluence 1064 nm Q-switched Nd:YAG laser: Laser toning in Caucasian women.
    Micek I; Pawlaczyk M; Kroma A; Seraszek-Jaros A; Urbańska M; Gornowicz-Porowska J
    Lasers Surg Med; 2022 Mar; 54(3):366-373. PubMed ID: 34473361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Q-Switched Laser Combined with Intense Pulsed Laser in the Treatment of Melasma Based on Reflection Confocal Microscope.
    Xu J; Pu Y
    Comput Math Methods Med; 2022; 2022():4413130. PubMed ID: 35813427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of low-fluence 1064 nm Q-switched Nd: YAG laser for the treatment of melasma: A meta-analysis and systematic review.
    Chen J; Yu N; Peng L; Li H; Tang Y; Ou S; Zhu H
    J Cosmet Dermatol; 2022 Jul; 21(7):. PubMed ID: 35621242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.